PepCalcs
    Back to Library

    Cortagen

    Research Use OnlyPreclinical (in vitro, animal models, and small Russian clinical studies).

    Cortagen

    Description

    A brain bioregulator peptide supporting cortical function and cognitive health. Used in neurological longevity protocols.

    Dose:2 mg
    Frequency:30 days in a row, 2-3x per year
    Administration Method: SQ
    CategoryBioregulator
    Half-LifeVery short (minutes); typical of Khavinson short peptides.

    Overview

    Cortagen is a brain-cortex-derived peptide bioregulator in the Khavinson short-peptide family. It is studied for neuroprotection, cortical function in aging, and peripheral nerve regeneration.

    Mechanism of Action

    Cortagen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro, AEDP) developed by Vladimir Khavinson. It is proposed to act through tissue-preferential gene-expression effects in the brain cortex via chromatin remodeling and modulation of transcription, supporting neuroprotection and peripheral nerve regeneration.

    Benefits

    • •Brain health
    • •Cognitive support
    • •Neuroprotection
    • •Mental clarity

    Reported Side Effects

    • •Limited human safety data
    • •Possible injection site reactions

    Scientific References

    Related Bioregulator Peptides